Cargando…
Understanding alternative splicing of Ca(v)1.2 calcium channels for a new approach towards individualized medicine
Calcium channel blockers (CCBs) are widely used to treat cardiovascular diseases such as hypertension, angina pectoris, hypertrophic cardiomyopathy, and supraventricular tachycardia. CCBs selectively inhibit the inward flow of calcium ions through voltage-gated calcium channels, particularly Ca(v)1....
Autores principales: | Liao, Ping, Soong, Tuck Wah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596553/ https://www.ncbi.nlm.nih.gov/pubmed/23554629 http://dx.doi.org/10.1016/S1674-8301(10)60027-9 |
Ejemplares similares
-
Alternative Splicing of L-type Ca(V)1.2 Calcium Channels: Implications in Cardiovascular Diseases
por: Hu, Zhenyu, et al.
Publicado: (2017) -
Enhanced long-term potentiation and impaired learning in mice lacking alternative exon 33 of Ca(V)1.2 calcium channel
por: Navakkode, Sheeja, et al.
Publicado: (2022) -
Aberrant Splicing Promotes Proteasomal Degradation of L-type Ca(V)1.2 Calcium Channels by Competitive Binding for Ca(V)β Subunits in Cardiac Hypertrophy
por: Hu, Zhenyu, et al.
Publicado: (2016) -
β subunits of voltage-gated calcium channels in cardiovascular diseases
por: Loh, Kelvin Wei Zhern, et al.
Publicado: (2023) -
T Cell Receptor Mediated Calcium Entry Requires Alternatively Spliced Ca(v)1.1 Channels
por: Matza, Didi, et al.
Publicado: (2016)